Follow
Elsa Y Pioli
Elsa Y Pioli
Motac Neurosciences Ltd
Verified email at motac.com - Homepage
Title
Cited by
Cited by
Year
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa‐induced dyskinesia
E Bezard, E Tronci, EY Pioli, Q Li, G Porras, A Björklund, M Carta
Movement Disorders 28 (8), 1088-1096, 2013
1572013
RGS9–2 negatively modulates L-3, 4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease
SJ Gold, CV Hoang, BW Potts, G Porras, E Pioli, KW Kim, A Nadjar, C Qin, ...
Journal of Neuroscience 27 (52), 14338-14348, 2007
1442007
Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for “NMDA antagonist modelling” of schizophrenia
G Gilmour, EY Pioli, SL Dix, JW Smith, MW Conway, WT Jones, S Loomis, ...
Psychopharmacology 205, 203-216, 2009
962009
Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats
EY Pioli, W Meissner, R Sohr, CE Gross, E Bezard, BH Bioulac
Neuroscience 153 (4), 1213-1224, 2008
852008
The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model
E Bezard, EY Pioli, Q Li, F Girard, V Mutel, C Keywood, F Tison, O Rascol, ...
Movement Disorders 29 (8), 1074-1079, 2014
772014
Animal models of l-DOPA–induced dyskinesia: an update on the current options
H Iderberg, V Francardo, EY Pioli
Neuroscience 211, 13-27, 2012
732012
Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia
E Bézard, A Munoz, E Tronci, EY Pioli, Q Li, G Porras, A Björklund, ...
Neuroscience research 77 (4), 242-246, 2013
592013
An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-treated macaque models
WKD Ko, SM Camus, Q Li, J Yang, S McGuire, EY Pioli, E Bezard
Neuropharmacology 110, 48-58, 2016
562016
An m G lu4‐P ositive A llosteric M odulator A lleviates P arkinsonism in P rimates
D Charvin, T Di Paolo, E Bezard, L Gregoire, A Takano, G Duvey, E Pioli, ...
Movement Disorders 33 (10), 1619-1631, 2018
542018
An automated maze task for assessing hippocampus-sensitive memory in mice
EY Pioli, BN Gaskill, G Gilmour, MD Tricklebank, SL Dix, D Bannerman, ...
Behavioural brain research 261, 249-257, 2014
542014
Why bother using non-human primate models of cognitive disorders in translational research?
S Camus, WKD Ko, E Pioli, E Bezard
Neurobiology of Learning and Memory 124, 123-129, 2015
532015
Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP)‐lesioned primate model of …
WKD Ko, E Pioli, Q Li, S McGuire, A Dufour, TB Sherer, E Bezard, ...
Movement Disorders 29 (6), 772-779, 2014
502014
Levodopa improves motor deficits but can further disrupt cognition in a macaque Parkinson model
JS Schneider, EY Pioli, Y Jianzhong, Q Li, E Bezard
Movement Disorders 28 (5), 663-667, 2013
412013
µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease
E Bezard, Q Li, H Hulme, E Fridjonsdottir, A Nilsson, E Pioli, PE Andren, ...
Journal of Neuroscience 40 (35), 6812-6819, 2020
272020
Vector-mediated l-3,4-dihydroxyphenylalanine delivery reverses motor impairments in a primate model of Parkinson’s disease
C Rosenblad, Q Li, EY Pioli, S Dovero, ASLM Antunes, L Agúndez, ...
Brain 142 (8), 2402-2416, 2019
192019
Effects of memantine and galantamine on cognitive performance in aged rhesus macaques
JS Schneider, EY Pioli, Y Jianzhong, Q Li, E Bezard
Neurobiology of Aging 34 (4), 1126-1132, 2013
182013
Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonism
J Baufreton, T Milekovic, Q Li, S McGuire, EM Moraud, G Porras, S Sun, ...
Movement Disorders 33 (10), 1632-1642, 2018
152018
Engrailed‐1 induces long‐lasting behavior benefit in an experimental Parkinson primate model
N Thomasson, E Pioli, C Friedel, A Monseur, J Lavaur, KL Moya, ...
Movement Disorders 34 (7), 1082-1084, 2019
142019
Intraventricular dopamine infusion alleviates motor symptoms in a primate model of Parkinson's disease
C Moreau, AS Rolland, E Pioli, Q Li, P Odou, C Barthelemy, D Lannoy, ...
Neurobiology of Disease 139, 104846, 2020
122020
Meta‐analysis of amantadine efficacy for improving preclinical research reliability
P Stanley, EY Pioli, R Kozak, M Popiolek, E Bezard
Movement Disorders 33 (10), 1555-1557, 2018
92018
The system can't perform the operation now. Try again later.
Articles 1–20